ARCHIVES

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

ACS Study Finds Low Tar Cigarettes Cause Few Lung Abnormalities

March 2, 1979

Prevention Clinical Trials Heads Greenwalk Priority Lists For ‘86

February 8, 1985

Reports On Nutrition & Cancer Show Needs For More Clinical Studies

September 5, 1975

Are Lab Budgets Excessive? Views On Intramural Program

April 21, 1995

NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available

July 11, 2014

In Brief: NCAB Approves Concept Of Converting Baltimore Program To Cancer Center; New DCCP Labs Named

June 5, 1981